Performance analysis of Sunshine Biopharma Inc - Warrants (15/02/2027) (SBFMW)
Annual Return
Over the past 3 years, SBFMW has had an average annual return of -49.05%, underperforming the benchmark SPY, which returned +22.45% annual.
Since Feb 15, 2022, SBFMW has had an average annual return of -43.88%, underperforming the benchmark SPY, which returned +14.54% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -73.63% | +18.08% | -19.53% | -38.88% | -45.47% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.27% | -5.83% | -11.75% | -7.06% | -41.82% | -38.06% | -73.63% | ||||||
| 2025 | +49.14% | -35.43% | +30.08% | +4.11% | +13.87% | +19.26% | -22.84% | -29.28% | -5.56% | +89.54% | -10.19% | -24.00% | +18.08% |
| 2024 | -19.68% | -75.08% | +20.69% | +65.59% | +0% | -12.45% | +14.57% | +24.68% | +4.98% | -12.40% | +80.50% | -3.07% | -19.53% |
| 2023 | +78.29% | -9.98% | -4.79% | -7.99% | -32.61% | +21.97% | +7.16% | -51.87% | +15.14% | +24.72% | -28.61% | +0.03% | -38.88% |
| 2022 | -41.65% | +182.74% | +119.22% | -38.71% | -38.35% | +3.64% | -14.11% | -38.36% | +34.44% | -19.50% | -32.82% | -45.47% |
Drawdown analysis of Sunshine Biopharma Inc - Warrants (15/02/2027) (SBFMW)
The maximum drawdown for the SBFMW was -99.52%, occurring on Mar 13, 2024. This drawdown has not yet recovered.
The current SBFMW drawdown is -99.33%.
Since Feb 15, 2022 SBFMW has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.52% | Apr 7, 2022 | 483 | Mar 13, 2024 | Ongoing | Ongoing | Ongoing |
| -41.65% | Feb 15, 2022 | 8 | Feb 28, 2022 | 7 | Mar 9, 2022 | 15 |
| -31.16% | Mar 16, 2022 | 10 | Mar 30, 2022 | 4 | Apr 5, 2022 | 14 |
| -16.66% | Mar 11, 2022 | 1 | Mar 14, 2022 | 1 | Mar 15, 2022 | 2 |